首页 | 本学科首页   官方微博 | 高级检索  
     

左氧氟沙星对初治涂阳肺结核疗效分析
引用本文:赖静文,郭婉如.左氧氟沙星对初治涂阳肺结核疗效分析[J].中国热带医学,2017(4):424-426.
作者姓名:赖静文  郭婉如
作者单位:广州市番禺区慢性病防治站,广东广州,511400
摘    要:目的探讨采用左氧氟沙星对初治涂阳肺结核的疗效。方法将2016年1月—5月在结核病防治科登记治疗的120例初治涂阳肺结核患者随机分为3组,分别以A组(左氧氟沙星组)4HRZEL/2HR,B组(强化期延长方案组)4HRZE/2HR,C组(标准方案组)2HRZE/4HR方案进行6个月抗结核治疗。结果 3组2月末痰培养阴转率分别为91.7%,77.1%,82.9%,5月末痰培养阴转率分别为100.0%,91.4%,85.7%,6月末痰培养阴转率分别为100.0%,94.3%,88.6%,3组间痰菌阴转率差异无统计学意义(P0.05)。3组6月末病灶明显吸收率分别为80.6%,54.3%,45.7%,A组明显高于B组和C组(P0.05)。3组6月空洞闭合率分别为95.0%,75.0%,62.5%,A组高于C组(P0.05),但与B组比较差异无统计学意义(P=0.077)。结论 4HRZEL/2HR治疗方案可提高初治涂阳肺结核治愈率和病灶吸收率,但仍需进一步研究。

关 键 词:肺结核  初治  涂阳  标准化疗方案  耐药  左氧氟沙星

Levofloxacin on primary smear positive pulmonary tuberculosis
LAI Jingwen,GUO Wanru.Levofloxacin on primary smear positive pulmonary tuberculosis[J].China Tropical Medicine,2017(4):424-426.
Authors:LAI Jingwen  GUO Wanru
Abstract:Objective To investigate the curative effect of different chemotherapy regimens in the treatment of newly diagnosed smear positive pulmonary tuberculosis.Methods A total of 120 patients with newly diagnosed smear positive pulmonary tuberculosis were randomly divided into 3 groups from January 2016 to May 2016, group A (levofloxacin group) 4HRZEL/2HR, group B (extended period group) 4HRZE/2HR, group C (standard group) 2HRZE/4HR with 6 months of anti tuberculosis scheme.Results Three groups of at the end of two months sputum culture negative conversion rate were 91.7%, 77.1%, 82.9%, at the end of five months sputum culture negative conversion rate were 100.0%, 91.4%, 85.7%, at the end of six months sputum culture negative conversion rate were 100.0%, 94.3%, 88.6%.There was no significant difference between the three groups in sputum negative conversion rate (P>0.05).Three groups at the end of six months, the absorption rate of lesions was 80.6%, 54.3%, 45.7%, group A was significantly higher than that of group B and group C (P<0.05).The closure rate of the three groups was 95.0%, 75.0%, 62.5% at the end of six months, group A was higher than group C (P<0.05).However, there was no significant difference between the group B and group A (P=0.077).Conclusion 4HRZEL/2HR treatment can improve the cure rate and the absorption rate of smear positive pulmonary tuberculosis, but it still needs further research.
Keywords:pulmonary tuberculosis  initial treatment  smear positive  standard chemotherapy regimen  drug resistance  levofloxacin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号